Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer

Abstract

The coagulation pathway seems to be activated in urological malignancies. Specific panels of coagulation factors might play a role as screening or prognostic tools in earlier stages of renal, prostate and bladder cancer. Further research should also focus on their role in the association of cancer with thromboembolic events.